Metabolomics Pans Out, Identifies Potential Prostate Cancer Marker
This article was originally published in Start Up
Executive Summary
New research has identified a novel marker for prostate cancer whose expression is directly dependent on the severity of the disease and can be detected non-invasively in urine. In addition to its potential as a screening test, the marker, sarcosine, could be a target for the development of new prostate cancer therapies